AmerisourceBergen sees operating profits fall; Recordati buys Tunisian drugmaker;

@EricPFierce: CMO Exela looks to get $1 million USDA loan to help expand plant, add jobs. Story | Follow @EricPFierce

> AmerisourceBergen ($ABC) saw its operating earnings fall nearly 10% as it finished up its new strategic long-term relationship with Walgreen and Alliance Boots. Release

> South Africa's Aspen Pharmacare would get a manufacturing plant as part of a deal to buy GlaxoSmithKline's ($GSK) heart drugs Arixtra and Fraxiparine for about $1.1 billion. Story

> Sanofi ($SNY) and Carlyle are both talking to Elder about buying its formulations business. Story

> Integrated DNA Technologies (IDT) has opened an operation in Singapore for manufacturing oligonucleotides for research companies. Item

And Finally... Italian pharma company Recordati will pay about €37 million to buy a 90% interest in Tunisian drugmaker Opalia Pharma, including its manufacturing operations. Story